From latest presentation.... Possibly something about this....
JOINT DEVELOPMENT AGREEMENT WITH MINERAL RESOURCES LIMITED NEAR COMPLETION
During the quarter, Lithium Australia drew down a further ~A$1.2m of the A$4.5m convertible note, issued by
Mineral Resources Limited (“MinRes”) as part of the joint development agreement (“JDA”) announced on 7
August 2023 related to disruption lithium processing technology, LieNA®. The proceeds funded final stage piloting
activities and the demonstration plant engineering study. As of Q1 FY25, the Company has drawn ~A$4.2m of the
A$4.5m convertible note.
Lithium Australia has also announced that the operation of the pilot plant is now complete, with the lithium
phosphate produced being analysed to determine final product specifications in preparation for refining. This
analysis and associated refining are expected to be completed by the end of 2024.In addition, the engineering
study and layout development are largely complete, with cost estimation activities well progressed.
Subject to the results of final product analysis and completion of the engineering study, Lithium Australia and
MinRes will form a 50:50 joint venture (“JV”) to commercialise the LieNA® technology through a licensing model.
The JV will wholly own the LieNA® technology and expects to license the technology to third parties at a target
headline gross product royalty rate of 8%. The first license issued by the JV is expected to be for the demonstration
plant. Following this initial license, the JV expects to issue licenses to greenfield and brownfield spodumene mines
globally.
- Forums
- ASX - By Stock
- LIT
- Ann: Pause in Trading
LIT
livium ltd
Add to My Watchlist
9.09%
!
1.0¢

Ann: Pause in Trading, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $16.90M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $3.966K | 396.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 1062786 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 1381891 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 819036 | 0.010 |
30 | 7595735 | 0.009 |
46 | 18574453 | 0.008 |
18 | 10941696 | 0.007 |
7 | 5078340 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 1381891 | 16 |
0.012 | 6858977 | 19 |
0.013 | 4817889 | 4 |
0.014 | 720000 | 4 |
0.015 | 897700 | 5 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
LIT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online